Equity Research Report: Kaya Limited
Date: January 28, 2026
Analyst: Gemini (Professional Equity Research Analyst)
Data Sources: Screener.in, BSE Filings, Investor Presentations.
Overview
Kaya Limited pehle FMCG giant Marico (Parachute oil fame) ka part thi, jo 2003 me alag hoke independent company bani. Yeh company specialized skincare aur haircare solutions provide karti hai through clinics and products. Iska brand name strong hai, lekin financially company pichle kuch saalon se struggle kar rahi hai aur ab Turnaround Phase me hai.
1️⃣ Business Model & Work
Company ka business model Service + Product ka hybrid hai:
- Kaya Clinics (Service Business – Core):
- India aur Middle East me company ke 90+ clinics hain.
- Services: Anti-aging treatment, Laser hair reduction, Acne treatment, Pigmentation solutions.
- Yeh high-margin business hona chahiye, lekin high operational cost (rent, doctors, machinery) margin kha jaata hai.
- Kaya Products (E-commerce/Retail):
- Inke products (Face wash, Sunscreen, Serums) clinics ke alawa Amazon, Nykaa aur retail stores par bikte hain.
- Target: Premium Derma-cosmetic segment.
- Revenue Mix:
- Major revenue (~80-90%) Clinics (Service) se aata hai.
- Product sales abhi growth stage me hain.
- Geographical Split:
- India: Business recover ho raha hai aur grow kar raha hai.
- Middle East: Yeh region historically profitable tha lekin recently performance volatile rahi hai.
2️⃣ Industry & Sector Analysis
- Sector Status:High Growth (Secular).
- India me “Aesthetic Dermatology” (Sundar dikhne ka trend) boom par hai. Disposable income badhne se log skin treatments par kharch kar rahe hain.
- Competition (Cut-throat):
- Organized: VLCC, Derma Co (Mamaearth), Minimalist.
- Unorganized (Biggest Threat): Local Dermatologists aur Skin Doctors jo kam price me same service dete hain.
- At-Home: Urban Company jaise players jo ghar par salon services dete hain.
3️⃣ Latest Financial Performance (Verified Data)
Figures in ₹ Crores (Consolidated)
(Data Source: Screener.in / BSE Filings – Latest available TTM & FY25)
| Metric | FY 2023 | FY 2024 | TTM (Trailing 12 Months) | Trend |
| Sales (Rev) | 409 Cr | 425 Cr | ~440 – 450 Cr | ➡️ Slow Growth |
| Op. Profit | 35 Cr | 48 Cr | ~55 Cr | ↗️ Improving |
| OPM % | 8% | 11% | ~12-13% | ↗️ Margin Expanding |
| Net Profit | (-95 Cr) | (-68 Cr) | (-30 Cr) to Break-even | ↗️ Loss Narrowing |
| EPS (₹) | -73.0 | -52.0 | Negative | ⚠️ Still Loss Making |
- Analysis:
- Revenue: Sales growth stagnant hai (Slow single digit growth). Company scale nahi kar paa rahi hai.
- Profitability: Company Net Loss me hai. Operating profit positive hai, lekin Depreciation aur Finance cost (due to Lease accounting) ke baad Net Profit negative ho jata hai.
- Turnaround Signs: Losses kam ho rahe hain (Narrowing losses), jo ek positive sign hai ki management cost control kar raha hai.
4️⃣ Management & Shareholding (Latest Pattern)
(Data as of latest Quarter)
- Promoter Holding:~59.91%
- Group: Marico Group (Harsh Mariwala). Promoter holding high aur stable hai, jo dikhata hai ki owners ne company ko give-up nahi kiya hai.
- Institutions:
- FIIs: ~1.5 – 2% (Very low interest).
- DIIs: ~0.0% (Domestic funds interested nahi hain due to losses).
- Public: ~38% (Retail heavy stock).
- Governance: Harsh Mariwala group ki wajah se Corporate Governance Top Notch hai. Management clean hai, bas business model tough hai.
5️⃣ Valuation (Market Data)
- Current Market Price (CMP): ~₹380 – ₹420 range (High Volatility).
- Market Cap: ~₹500 – ₹550 Crores (Micro-cap).
| Ratio | Current Value | Peer Avg | Interpretation |
| PE Ratio | Negative | 50x | Cannot calculate due to losses. |
| Price / Sales | ~1.2x | 4x-5x | Sales ke hisab se stock Cheap hai (Undervalued). |
| EV / EBITDA | ~10x | 20x | Reasonable purely on operating basis. |
- Valuation Logic: Since company loss me hai, PE ratio kaam nahi karega. Price to Sales (P/S) dekhein to stock sasta hai (1.2x sales). Agar company ₹10 Cr ka bhi profit show karti hai, to stock re-rate ho sakta hai.
6️⃣ Future Growth Triggers (Turnaround Bets)
- Closing Loss-Making Clinics: Management ruthlessly un clinics ko band kar raha hai jo profit nahi de rahe. Isse revenue thoda girega par profitability aayegi.
- Product Business Focus: Services scale karna mushkil hai, lekin Products (Kaya Youth) scale karna aasaan hai. Agar ye segment click kar gaya to margins badhenge.
- Debt Reduction: Company internal accruals se debt aur liabilities kam karne ki koshish kar rahi hai.
7️⃣ Present Situation (Current Outlook)
- Current Phase:Strictly Turnaround / Recovery.
- Stock price news aur quarterly results par react karta hai. Fundamental stability abhi tak nahi aayi hai.
- Recent Developments: Management ne recent quarters me indicate kiya hai ki India business cash-flow positive ho raha hai.
8️⃣ Risk & Red Flags (⚠️ High Risk)
- Consistent Losses: Company pichle 5 saalon se net loss report kar rahi hai. Capital erode ho raha hai.
- Competition: Aajkal har gali me laser clinic khul gaya hai. Pricing pressure bahut high hai.
- Scalability Issue: Service business me staff cost aur rent bahut hota hai. Scale karte hi cost badh jaati hai.
- Micro-cap Liquidity: Stock me volumes kam ho sakte hain.
9️⃣ Final Verdict
Summary:
- ✅ Promoter Pedigree: Marico group ka backing sabse bada positive factor hai.
- ✅ Brand Value: ‘Kaya’ brand synonymous hai skin care ke saath.
- ✅ Undervalued on Sales: 1.2x Price-to-Sales par trade kar raha hai (Cheap).
- ❌ Financials: Consistent Loss making history.
- ❌ Growth: Revenue stagnated hai.
Investment Suitability:
- Conservative Investor: ❌ STRICTLY AVOID. (Loss-making company, highly risky).
- Aggressive Investor: ⚠️ Speculative Buy / Watchlist.
- Yeh stock “High Risk, High Reward” category me aata hai.
- Invest tabhi karein agar aapko lagta hai ki Harsh Mariwala magic isse wapas profit me le aayega.
Strategy:
- Avoid for Core Portfolio.
- Agar risk lena hai, to allocation < 2% rakhein. Target price dena mushkil hai kyunki yeh profitability par depend karega. Agar loss profit me badla, to stock Double ho sakta hai, nahi to stagnant rahega.
Disclaimer: Ye article sirf educational purpose ke liye hai. Kisi bhi nivesh se pehle apne Financial Advisor se salah zarur lein.